Parenteral Nutrition Market is expected to reach USD 8.29 Billion by year 2026| Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Hospira Inc., etc.

According to the current analysis of Reports and Data, the global Parenteral Nutrition market was valued at USD 5.3 Billion in 2018 and is expected to reach USD 8.29 Billion by year 2026, at a CAGR of 5.8 %. Parenteral nutrition, or intravenous nutrition, is a method of bringing nutrition to your body through the veins. This form of diet is used to help people who cannot draw their essential nutrients from food. It has become a well-established intervention for the following indications: to maintain the lives of patients with short bowel syndrome; for perioperative use in patients with nutritional deprivation; to improve the quality of life of patients with inflammatory bowel disease; to help with the healing of enter-cutaneous and pancreatic fistulas. Also, used widely for hypermetabolic conditions such as sepsis, trauma, burns, and acquired immune deficiency syndrome; in neonatal and pediatric patients. It is considered to be a crucial source for meeting the nutritional needs of the body, especially in cancer patients.

Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/2034

Companies considered and profiled in this market study

Baxter International Inc.; Grifols International S.A.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Hospira Inc., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical, Pfizer and Aculife (Nirlife).

According to the World Health Organization, cancer is the second leading cause of death in the world and is responsible for about 9.6 million deaths in 2018. Worldwide, approximately one in six deaths are due to cancer. With an increase in the number of cancer cases, the demand is expected to increase with a high CAGR. In addition to cancer, other health issues such as Crohn's disease, ischemic bowel disease, and increased prevalence of chronic diseases have increased adoption provide patients with essential nutrients. These nutrients are vital for maintaining high levels of energy, hydration, and strength. Besides, the growing gap between needs and the actual absorption of essential nutrients into the body is fueling up the industry.

Increase in geriatric population has led to an increase in the number of patients being admitted in the healthcare institutions and hospital eventually increasing the demand. Growing awareness and rise in disposable income has led to an increased adoption. Rising metabolic disorders and chronic illness is expected to further drive the growth of the industry. However, strict rules and regulations laid down by the government associated with approval of parenteral nutrition and lack of awareness among the people are the major hindrance for industry during 2019-2026.

Further key findings from the report suggest

1. As of 2018, Single Dose Amino Acid Solution is the dominating the industry which holds 32.7% of the global market. North American regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions

2. It is also considered to be a life-saving therapy, but it is complex. Some of these complications include infection, metabolic; however, management by an interdisciplinary nutritional support team can optimize outcomes for patients associated with this therapy.

3. In addition, the launch of innovative and compelling products is driving the growth of the market due to increased adoption. For example, the Celsite Power, injectable access ports, launched by B. Braun Melsungen offer high security and reliability to patients, nurses, doctors, and hospital administrators.

4. To increase the market share, manufacturers are introducing new client-centered therapies. For example, infusion therapy, depending on the underlying disease, the solution contains a suitable active pharmaceutical ingredient.

Ask Here to Get customization & Check for irresistible discount rates on this report @ https://www.reportsanddata.com/discount-enquiry-form/2034

For the purpose of this report, Reports and Data has segmented the Parenteral Nutrition market on the basis of nutrient type, consumer type, end use, and region:

Nutrient Type (Revenue, USD Million; 2016-2026)

Carbohydrates
Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

Consumer Type (Revenue, USD Million; 2016-2026)

Children & New-born
Adults

End Use (Revenue, USD Million; 2016-2026)

Hospital
Clinic
Others

Regional Outlook (Revenue in USD Million; 2016-2026)

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Find the extensive Report Description, TOC and Table of Figure: https://www.reportsanddata.com/report-detail/parenteral-nutrition-market

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.